TY - JOUR T1 - Effect of multiple freeze-thaw cycles on detection of anti-SARS-CoV-2 IgG antibodies JF - medRxiv DO - 10.1101/2021.04.13.21255379 SP - 2021.04.13.21255379 AU - Farah M. Shurrab AU - Duaa W. Al-Sadeq AU - Fathima Amanullah AU - Salma N. Younes AU - Hadeel Al-Jighefee AU - Nadin Younes AU - Soha R. Dargham AU - Hadi M. Yassine AU - Laith J. Abu Raddad AU - Gheyath K. Nasrallah Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/19/2021.04.13.21255379.abstract N2 - Several studies have investigated the effect of repeated freeze-thaw (F/T) cycles on RNA detection for SARS-CoV-2. However, no data is available regarding the effect of repeated F/T cycles on SARS-CoV-2 antibody detection in serum. We investigated the effect of multiple F/T cycles on anti-SARS-CoV-2 IgG detection using an ELISA test targeting the nucleocapsid antibodies. Ten positive and one negative SARS-CoV-2 IgG sera from 11 participants, in replicates of five were subjected to a total of 16 F/T cycles and stored at 4°C until tested by ELISA. Statistical analysis was done to test for F/T cycle effect. Non-of the 10 positive sera turned into negative after 16 F/T cycles. There was no significant difference in the OD average reading between the first and last F/T cycles, except for one serum with a minimal decline in the OD. The random-effect linear regression of log (OD) on the number of cycles showed no significant trend with a slope consistent with zero (B=-0.0001; 95% CI −0.0008; 0.0006; p-value=0.781). These results suggest that multiple F/T cycles had no effect on the ability of the ELISA assay to detect the SARS-CoV-2 IgG antibodies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by grant No. RRC-2-032 from the Qatar National Research Fund (a member of Qatar Foundation) and Qatar University's internal grant QUERG-CMED-2020-2Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Medical Research Center (MRC) Ethics Committee, approval number MRC-05-136, and Qatar University Institutional Review Board approval number QU-IRB 1492-E/21All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe were constrained by our local, internal ethics policies, which entail confidentiality and therefore anonymity with regard to the samples for analysis in studies of this nature. Disclosing raw data will be breaching participant confidentiality requests to access the data should be addressed to the Ethical committee of Qatar University ER -